Ying Wang

Impact of Visual Field Loss on Health-Related Quality of Life in Glaucoma

Roberta McKean‐Cowdin, Ying Wang, Joanne Wu et al. · Ophthalmology · 2007 · 339 citations · Full text

Diabetic Retinopathy, Ocular Disease, Ophthalmology +5

Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1α/VEGF/VEGFR2 pathway and M1 type macrophage/microglia polarization

Jiaowen Xu, Yuanyuan Tu, Ying Wang et al. · Biomedicine & Pharmacotherapy · 2019 · 55 citations · Full text

A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells

Jingxia Du, Ying Wang, Yuanyuan Tu et al. · Experimental Eye Research · 2020 · 50 citations

Inflammation, Ocular Disease, Ophthalmology +10

Tissue factor induces VEGF expression via activation of the Wnt/β-catenin signaling pathway in ARPE-19 cells.

Ying Wang, Aimin Sang, Manhui Zhu et al. · PubMed · 2016 · 38 citations · Full text

<p>Frequency-dependent neural activity in primary angle-closure glaucoma</p>

Fei Jiang, Chen Yu, Minjing Zuo et al. · Neuropsychiatric Disease and Treatment · 2019 · 30 citations · Full text